Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)
Recruiting
N/A
Interventional Study
Gestational Diabetes Mellitus
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 51
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 90 (estimated)
- Sponsor
- Wolfson Medical Center · Government
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study evaluates the impact of incorporating home-ultrasound (home-US) devices into telemedicine care for patients with gestational diabetes mellitus (GDM). The study will compare satisfaction, clinical outcomes, and healthcare costs between standard high-risk pregnancy care and care augmented by home-US.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Singleton pregnancy
* GDM diagnosed by OGTT or glucose monitoring
* Hebrew speaking
* Compatible cellphone
Exclusion Criteria:
* Pregestational diabetes
* Fetal anomalies/genetic abnormalities
* Multifetal pregnancy
* Late GDM diagnosis (after 34 weeks)
Contacts